Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.
Paulson KG, Voillet V, McAfee MS, Hunter DS, Wagener FD, Perdicchio M, Valente WJ, Koelle SJ, Church CD, Vandeven N, Thomas H, Colunga AG, Iyer JG, Yee C, Kulikauskas R, Koelle DM, Pierce RH, Bielas JH, Greenberg PD, Bhatia S, Gottardo R, Nghiem P, Chapuis AG.
Paulson KG, et al. Among authors: gottardo r.
Nat Commun. 2018 Sep 24;9(1):3868. doi: 10.1038/s41467-018-06300-3.
Nat Commun. 2018.
PMID: 30250229
Free PMC article.